Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor
- 9 June 2009
- journal article
- case report
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 395 (2) , 185-192
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreasBritish Journal of Surgery, 2008
- Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictorsHPB, 2007
- Treatment with 90Y- and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumorsSurgery, 2006
- Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.2004
- Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.2002
- Yttrium-90 DOTATOC: first clinical resultsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Prospective study of aggressive resection of metastatic pancreatic endocrine tumors.1992
- Cytoreductive hepatic surgery for neuroendocrine tumors.1990
- Nonfunctioning malignant neuroendocrine tumors of the pancreas.1986